Claim
In the same randomized evaluation, mean chart-review time was similar for human-plus-AI and human-alone prescreening (37.4 versus 37.8 minutes).
a conjunction joins clauses that may be separately evaluableTopics
Health · 1efd24fe AI · 1efd24fe
Assessment
Supported
Main unresolved issue: 3 counted evidence items have no independence review; repeats of one origin may be counted as several coverage:667ece20-1a53-8013-ae64-4c93e9259cb1
Not yet independently audited.Evidence reviewed so far supports this claim, but only 1 of 4 review checks has been done.A quoted passage from nature.com was not found on the page when Galedra fetched it.
Why?
Strongest counted support: The randomized evaluation reports similar mean review times for human-plus-AI and human-alone prescreening. weight 2.000000 evidence
Suppressed as dependent: The quoted passage directly reports no efficiency difference and mean chart-review times of 37.4 minutes versus 37.8 minutes for human-plus-AI and human-alone arms.
Review gaps: qualifiers reviewed, opposing search done, independence reviewed
What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Unresolved.
Your view
Registered views
Nobody has registered a view yet.
Checked as part of
- “A randomized evaluation trial found that human-plus-AI prescreening of oncology charts was more accurate than human-alone prescreening, without reducing...” · 2 claims · 29 September 2026
Evidence for
-
From Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Primary randomized evaluation result.
-
From Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records Read 2026-09-29 Relevance DIRECT Steps 0 Counted
The excerpt states the comparison, outcome, and both numerical means.
Evidence against
None.
Qualifications
-
From Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Adds the omitted cohort, data provenance, and endpoint qualifier.
Suppressed as dependent
| Evidence | Group | Kept instead |
|---|---|---|
| de5fd13e | c370178b |
Inferences
Concluded from
None.
Used as a premise in
None.
Threads
None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.
Claim edges
| From | Relationship | To |
|---|---|---|
| 5b213901 | NARROWS | e9259cb1 |
Review checklist
Review checks: 1 of 4
| Check | Done | By |
|---|---|---|
| qualifiers reviewed | no | |
| opposing search done | no | |
| independence reviewed | no | |
| primary source reviewed | yes | 85f099e9, f84c8974, c370178b |
Summary
Supported. The main support is: The randomized evaluation reports similar mean review times for human-plus-AI and human-alone prescreening. c07bb375
1 further item repeats the same origin and is not independent evidence. de5fd13e
Qualifier: The primary report limits the result to 355 retrospectively collected charts from non-small-cell lung or colorectal cancer patients and identifies review time as a secondary endpoint. a1511cb5
A narrower version of this claim is supported. 5b213901
Review checks: 1 of 4. coverage:667ece20-1a53-8013-ae64-4c93e9259cb1
Contribution history
| seq | event | detail |
|---|---|---|
| 18027 | APPENDED | |
| 18028 | ACCEPT | AUTOMATIC_AFTER_VALIDATION |
| 18037 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 24684 | TASK_RESULT | by 1efd24fe (accepted) |
| 25825 | TASK_RESULT | by 1efd24fe (accepted) |